Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.25
CMN's Cash to Debt is ranked higher than
55% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.03 vs. CMN: 0.25 )
CMN' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: 0.25

Equity to Asset 0.67
CMN's Equity to Asset is ranked higher than
79% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. CMN: 0.67 )
CMN' s 10-Year Equity to Asset Range
Min: 0.37   Max: 0.81
Current: 0.67

0.37
0.81
Interest Coverage 29.80
CMN's Interest Coverage is ranked higher than
70% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.54 vs. CMN: 29.80 )
CMN' s 10-Year Interest Coverage Range
Min: 1.4   Max: 9999.99
Current: 29.8

1.4
9999.99
F-Score: 5
Z-Score: 8.56
M-Score: -2.61
WACC vs ROIC
17.55%
10.65%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 13.70
CMN's Operating margin (%) is ranked higher than
84% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. CMN: 13.70 )
CMN' s 10-Year Operating margin (%) Range
Min: 2.05   Max: 14.87
Current: 13.7

2.05
14.87
Net-margin (%) 8.26
CMN's Net-margin (%) is ranked higher than
80% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.36 vs. CMN: 8.26 )
CMN' s 10-Year Net-margin (%) Range
Min: -2.35   Max: 12.33
Current: 8.26

-2.35
12.33
ROE (%) 11.90
CMN's ROE (%) is ranked higher than
82% of the 281 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.53 vs. CMN: 11.90 )
CMN' s 10-Year ROE (%) Range
Min: 5.06   Max: 22.36
Current: 11.9

5.06
22.36
ROA (%) 8.15
CMN's ROA (%) is ranked higher than
86% of the 294 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.84 vs. CMN: 8.15 )
CMN' s 10-Year ROA (%) Range
Min: 2.4   Max: 15.4
Current: 8.15

2.4
15.4
ROC (Joel Greenblatt) (%) 54.52
CMN's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. CMN: 54.52 )
CMN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 18.58   Max: 61.08
Current: 54.52

18.58
61.08
Revenue Growth (3Y)(%) 12.60
CMN's Revenue Growth (3Y)(%) is ranked higher than
90% of the 259 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. CMN: 12.60 )
CMN' s 10-Year Revenue Growth (3Y)(%) Range
Min: -0.6   Max: 29.4
Current: 12.6

-0.6
29.4
EBITDA Growth (3Y)(%) 24.50
CMN's EBITDA Growth (3Y)(%) is ranked higher than
89% of the 224 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.90 vs. CMN: 24.50 )
CMN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 1.2   Max: 40.8
Current: 24.5

1.2
40.8
EPS Growth (3Y)(%) 25.20
CMN's EPS Growth (3Y)(%) is ranked higher than
88% of the 222 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. CMN: 25.20 )
CMN' s 10-Year EPS Growth (3Y)(%) Range
Min: -6.3   Max: 46.5
Current: 25.2

-6.3
46.5
» CMN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

CMN Guru Trades in Q1 2014

RS Investment Management 4,606 sh (New)
Jim Simons 67,550 sh (+55.82%)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Mario Gabelli 415,509 sh (-2.00%)
Chuck Royce 72,438 sh (-19.81%)
» More
Q2 2014

CMN Guru Trades in Q2 2014

Joel Greenblatt 21,913 sh (New)
RS Investment Management 6,306 sh (+36.91%)
Mario Gabelli 395,973 sh (-4.70%)
Chuck Royce 58,438 sh (-19.33%)
Jim Simons 45,450 sh (-32.72%)
» More
Q3 2014

CMN Guru Trades in Q3 2014

RS Investment Management Sold Out
Mario Gabelli 389,748 sh (-1.57%)
Joel Greenblatt 17,444 sh (-20.39%)
Chuck Royce 46,438 sh (-20.53%)
Jim Simons 33,650 sh (-25.96%)
» More
Q4 2014

CMN Guru Trades in Q4 2014

Ron Baron 605,100 sh (New)
Ken Fisher 5,501 sh (New)
Mario Gabelli 371,038 sh (-4.80%)
Chuck Royce 42,338 sh (-8.83%)
Joel Greenblatt 9,069 sh (-48.01%)
Jim Simons 15,100 sh (-55.13%)
» More
» Details

Insider Trades

Latest Guru Trades with CMN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 46.40
CMN's P/E(ttm) is ranked higher than
74% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.50 vs. CMN: 46.40 )
CMN' s 10-Year P/E(ttm) Range
Min: 9.24   Max: 46.8
Current: 46.4

9.24
46.8
Forward P/E 25.84
CMN's Forward P/E is ranked higher than
75% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 33.67 vs. CMN: 25.84 )
N/A
PE(NRI) 45.80
CMN's PE(NRI) is ranked higher than
75% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 46.20 vs. CMN: 45.80 )
CMN' s 10-Year PE(NRI) Range
Min: 11.86   Max: 44.81
Current: 45.8

11.86
44.81
P/B 5.10
CMN's P/B is ranked higher than
57% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.76 vs. CMN: 5.10 )
CMN' s 10-Year P/B Range
Min: 0.77   Max: 5.3
Current: 5.1

0.77
5.3
P/S 3.80
CMN's P/S is ranked higher than
58% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.96 vs. CMN: 3.80 )
CMN' s 10-Year P/S Range
Min: 0.51   Max: 3.9
Current: 3.8

0.51
3.9
PFCF 41.70
CMN's PFCF is ranked higher than
78% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 69.28 vs. CMN: 41.70 )
CMN' s 10-Year PFCF Range
Min: 7.31   Max: 809.8
Current: 41.7

7.31
809.8
POCF 31.72
CMN's POCF is ranked higher than
73% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.15 vs. CMN: 31.72 )
CMN' s 10-Year POCF Range
Min: 5.66   Max: 50.61
Current: 31.72

5.66
50.61
EV-to-EBIT 28.53
CMN's EV-to-EBIT is ranked higher than
76% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.73 vs. CMN: 28.53 )
CMN' s 10-Year EV-to-EBIT Range
Min: 7.3   Max: 34.9
Current: 28.53

7.3
34.9
PEG 2.57
CMN's PEG is ranked higher than
93% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. CMN: 2.57 )
CMN' s 10-Year PEG Range
Min: 0.55   Max: 7.92
Current: 2.57

0.55
7.92
Shiller P/E 62.80
CMN's Shiller P/E is ranked higher than
75% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 180.80 vs. CMN: 62.80 )
CMN' s 10-Year Shiller P/E Range
Min: 8.99   Max: 62.8
Current: 62.8

8.99
62.8
Current Ratio 2.86
CMN's Current Ratio is ranked higher than
76% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. CMN: 2.86 )
CMN' s 10-Year Current Ratio Range
Min: 1.45   Max: 5.07
Current: 2.86

1.45
5.07
Quick Ratio 1.81
CMN's Quick Ratio is ranked higher than
71% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.79 vs. CMN: 1.81 )
CMN' s 10-Year Quick Ratio Range
Min: 0.88   Max: 2.41
Current: 1.81

0.88
2.41
Days Inventory 74.17
CMN's Days Inventory is ranked higher than
88% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 122.29 vs. CMN: 74.17 )
CMN' s 10-Year Days Inventory Range
Min: 55.68   Max: 147.15
Current: 74.17

55.68
147.15
Days Sales Outstanding 45.46
CMN's Days Sales Outstanding is ranked higher than
91% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 69.21 vs. CMN: 45.46 )
CMN' s 10-Year Days Sales Outstanding Range
Min: 42.46   Max: 87.67
Current: 45.46

42.46
87.67

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.20
CMN's Dividend Yield is ranked lower than
90% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.32 vs. CMN: 0.20 )
CMN' s 10-Year Dividend Yield Range
Min: 0.2   Max: 0.7
Current: 0.2

0.2
0.7
Dividend Payout 0.09
CMN's Dividend Payout is ranked higher than
98% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. CMN: 0.09 )
CMN' s 10-Year Dividend Payout Range
Min: 0.13   Max: 0.22
Current: 0.09

0.13
0.22
Dividend growth (3y) 19.30
CMN's Dividend growth (3y) is ranked higher than
87% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.40 vs. CMN: 19.30 )
CMN' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 19.3
Current: 19.3

0
19.3
Yield on cost (5-Year) 0.20
CMN's Yield on cost (5-Year) is ranked lower than
87% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.54 vs. CMN: 0.20 )
CMN' s 10-Year Yield on cost (5-Year) Range
Min: 0.2   Max: 0.7
Current: 0.2

0.2
0.7
Share Buyback Rate -2.10
CMN's Share Buyback Rate is ranked higher than
78% of the 231 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.60 vs. CMN: -2.10 )
CMN' s 10-Year Share Buyback Rate Range
Min: -0.5   Max: -13.3
Current: -2.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 34.80
CMN's Price/Tangible Book is ranked higher than
52% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.06 vs. CMN: 34.80 )
CMN' s 10-Year Price/Tangible Book Range
Min: 1.58   Max: 71.15
Current: 34.8

1.58
71.15
Price/DCF (Projected) 2.40
CMN's Price/DCF (Projected) is ranked higher than
79% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.81 vs. CMN: 2.40 )
CMN' s 10-Year Price/DCF (Projected) Range
Min: 0.59   Max: 5.04
Current: 2.4

0.59
5.04
Price/Median PS Value 2.70
CMN's Price/Median PS Value is ranked higher than
52% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.33 vs. CMN: 2.70 )
CMN' s 10-Year Price/Median PS Value Range
Min: 0.29   Max: 2.4
Current: 2.7

0.29
2.4
Price/Peter Lynch Fair Value 2.30
CMN's Price/Peter Lynch Fair Value is ranked higher than
92% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.00 vs. CMN: 2.30 )
CMN' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.47   Max: 7.59
Current: 2.3

0.47
7.59
Price/Graham Number 8.50
CMN's Price/Graham Number is ranked higher than
69% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.00 vs. CMN: 8.50 )
CMN' s 10-Year Price/Graham Number Range
Min: 0.92   Max: 9.15
Current: 8.5

0.92
9.15
Earnings Yield (Greenblatt) 3.60
CMN's Earnings Yield (Greenblatt) is ranked higher than
73% of the 293 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.50 vs. CMN: 3.60 )
CMN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.9   Max: 13.7
Current: 3.6

2.9
13.7
Forward Rate of Return (Yacktman) 21.93
CMN's Forward Rate of Return (Yacktman) is ranked higher than
93% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.09 vs. CMN: 21.93 )
CMN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 10.4   Max: 37.4
Current: 21.93

10.4
37.4

Analyst Estimate

Jul15
EPS($) 1.63
EPS without NRI($) 1.63

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:CI2.Germany,
Cantel Medical Corp was incorporated in Delaware. The Company is a provider of infection prevention and control products in the healthcare market. Its operating segments include: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, and Specialty Packaging. Endoscopy segment offers medical device reprocessing systems, disinfectants, detergents and other supplies used to high-level disinfect flexible endoscopes. This segment also offers disposable infection control products intended to eliminate the challenges associated with proper cleaning and high-level disinfection of numerous reusable components used in gastrointestinal (GI) endoscopy procedures. Water Purification and Filtration segment offers water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage and commercial industrial markets. The healthcare Disposables segment offers single-use, infection prevention and control healthcare products used principally in the dental market including face masks, sterilization pouches, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups and disinfectants. This segment also manufactures and provides biological and chemical indicators for sterility assurance monitoring services in the acute-care, alternate-care and dental markets. Dialysis segment offers medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. Specialty Packaging segment offers specialty packaging and thermal control products, as well as related compliance training, for the transport of infectious and biological specimens and thermally sensitive pharmaceutical, medical and other products. The Company sells and services its endoscope reprocessing equipment, high-level disinfectants, cleaners and consumables through its own United States field sales and service organization. Outside of the United States, it sells through independent distribution partners in Europe, Canada, Asia, Australia and Latin America as well as its own sales and service organizations in the Netherlands and Singapore. Its Competitors include Kimberly-Clark, 3M, Steris, Danaher/Sybron, Dentsply/Sultan Healthcare, Amcor. The Company's products are subject to regulation by the FDA, which regulates the testing, manufacturing, packaging, distribution and marketing of its medical devices and water purification devices in the United States.
» More Articles for CMN

Headlines

Articles On GuruFocus.com
Baron Small Cap Fund's Commentary on Cantel Medical Corp. Mar 19 2015 
Ron Baron's Top 5 New Holdings Feb 19 2015 
Small items not cut Mar 03 2013 
Cantel Medical Corp. (CMN) Sr. V.P., CFO and Treasurer Craig A Sheldon sells 2,607 Shares Mar 15 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Mar 11 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Dec 10 2010 
Cantel Medical Corp. Reports Operating Results (10-K) Oct 14 2010 
Cantel Medical Corp. Reports Operating Results (10-Q) Jun 09 2010 
Cantel Medical Corp. (CMN) President and CEO Andrew A Krakauer sells 11,505 Shares Apr 09 2010 
Cantel Medical Corp. (CMN) Chairman, 10% Owner Charles M Diker buys 5,000 Shares Oct 26 2009 

More From Other Websites
CANTEL MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 25 2015
CANTEL MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition Mar 23 2015
Cantel Medical Announces Appointment Of Peter G. Clifford As Executive Vice President and Chief... Mar 20 2015
CANTEL MEDICAL CORP Financials Mar 19 2015
Cantel Medical Announces Appointment Of Dr. Laura Forese To Its Board Of Directors Mar 19 2015
Cantel Medical Reports Results For The Second Quarter Ended January 31, 2015 Mar 19 2015
Cantel Medical Announces Appointment Of Dr. Laura Forese To Its Board Of Directors Mar 19 2015
Cantel Medical Beats Q2 Earnings, Provides Positive Outlook - Analyst Blog Mar 13 2015
CANTEL MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 12 2015
Cantel posts 2Q profit Mar 12 2015
Cantel posts 2Q profit Mar 12 2015
Cantel Medical Reports Results For The Second Quarter Ended January 31, 2015 Mar 12 2015
Q2 2015 Cantel Medical Corp Earnings Release - Before Market Open Mar 12 2015
Cantel Medical Corp. to Host Second Quarter 2015 Earnings Conference Call and Webcast Live on... Mar 11 2015
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January... Mar 05 2015
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January... Mar 05 2015
Cantel Medical Corp. To Present At The Sidoti & Company 19th Annual Emerging Growth Institutional... Mar 02 2015
Cantel Medical Corp. To Present At The Sidoti & Company 19th Annual Emerging Growth Institutional... Mar 02 2015
Medical Stocks Among The Latest Breakouts Feb 26 2015
Cantel Medical Acquires DentaPure® Dental Waterline Disinfection System Feb 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK